Viewing Study NCT03523858


Ignite Creation Date: 2025-12-25 @ 12:06 AM
Ignite Modification Date: 2025-12-25 @ 10:05 PM
Study NCT ID: NCT03523858
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-04
First Post: 2018-04-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module